Source: Eur Respir J, 55 (6) 2001130; 10.1183/13993003.01130-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martina M. De Santis, Darcy E. Wagner. Collagen IV: a critical new starting point for engineering upper airways. Eur Respir J, 55 (6) 2001130; 10.1183/13993003.01130-2020

Member's Comments

No comment yet.

Related content which might interest you: Collagen type III content in large airways and distal lung of fatal asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005 Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Lung tissue engineering: making a functional human lung Source: International Congress 2016 – Regeneratives approaches to COPD Year: 2016 More than mechanics: what determines the upper airway diameter? Source: Sleep and Breathing Conference 2021 Year: 2021 The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 A new piece in the puzzle: the eosinophil and the development of COPD Source: Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021 Year: 2021 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Bioengineered airway epithelial grafts with mucociliary function based on collagen IV- and laminin-containing extracellular matrix scaffolds Source: Eur Respir J, 55 (6) 1901200; 10.1183/13993003.01200-2019 Year: 2020 Upper and lower airways: the same tissue? Source: Eur Respir Monogr 2017; 76: 1-11 Year: 2017 Modifying remodelling and repair in ILD: a new therapeutic approach? Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease Year: 2006 Identifying a therapeutic target for ablating new blood vessel formation in patients with asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes Source: Eur Respir Mon; 2009: 46: 47–66 Year: 2009 Disruption of the lung structure maintenance programme: a comprehensive view of emphysema development Source: Eur Respir J 2011; 37: 752-754 Year: 2011 YI03 - Lung tissue engineering: generation and characterization of decellularized lung scaffolds for stem cell differentiation Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Hyaluronic acid increases the airway epithelial integrity Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD Year: 2005 Late stage of experimental pulmonary fibrosis is modulated by collagen V Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 Lung function in the elderly: time for new reference values? Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009